Global Live Attenuated Vaccine Market Research Report 2017

November 2017 | 103 pages | ID: G344FBA2A22EN
QYResearch

Abstracts

In this report, the global Live Attenuated Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Live Attenuated Vaccine in these regions, from 2012 to 2022 (forecast), covering

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Global Live Attenuated Vaccine market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

• Astellas Pharma (Japan)
• CSL Limited (Australia)
• Emergent BioSolutions (U.S.)
• GlaxoSmithKline (U.K.)
• Johnson & Johnson (U.S.)
• MedImmune (U.S.)
• Merck & Co (U.S.)
• Pfizer (U.S.)
• Sanofi Pasteur (France)
• Serum Institute of India Pvt (India)

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• By End User
• Pediatrics
• Adults
• By Disease Indication
• Pneumococcal
• Influenza
• HPV
• Hepatitis
• Rotavirus
• DTP
• Polio
• MMR

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

• Hospital
• Medical Center
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Live Attenuated Vaccine Market Research Report 2017

1 LIVE ATTENUATED VACCINE MARKET OVERVIEW

1.1 Product Overview and Scope of Live Attenuated Vaccine
1.2 Live Attenuated Vaccine Segment By End User
  1.2.1 Global Live Attenuated Vaccine Production and CAGR (%) Comparison By End User (Product Category)(2012-2022)
  1.2.2 Global Live Attenuated Vaccine Production Market Share By End User (Product Category) in 2016
  1.2.3 Pediatrics
  1.2.4 Adults
1.3 Live Attenuated Vaccine Segment By Disease Indication
  1.3.1 Pneumococcal
  1.3.2 Influenza
  1.3.3 HPV
  1.3.4 Hepatitis
  1.3.5 Rotavirus
  1.3.6 DTP
  1.3.7 Polio
  1.3.8 MMR
1.4 Global Live Attenuated Vaccine Segment by Application
  1.4.1 Live Attenuated Vaccine Consumption (Sales) Comparison by Application (2012-2022)
  1.4.2 Hospital
  1.4.3 Medical Center
  1.4.4 Others
1.5 Global Live Attenuated Vaccine Market by Region (2012-2022)
  1.5.1 Global Live Attenuated Vaccine Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
  1.5.2 North America Status and Prospect (2012-2022)
  1.5.3 Europe Status and Prospect (2012-2022)
  1.5.4 China Status and Prospect (2012-2022)
  1.5.5 Japan Status and Prospect (2012-2022)
  1.5.6 Southeast Asia Status and Prospect (2012-2022)
  1.5.7 India Status and Prospect (2012-2022)
1.6 Global Market Size (Value) of Live Attenuated Vaccine (2012-2022)
  1.6.1 Global Live Attenuated Vaccine Revenue Status and Outlook (2012-2022)
  1.6.2 Global Live Attenuated Vaccine Capacity, Production Status and Outlook (2012-2022)

2 GLOBAL LIVE ATTENUATED VACCINE MARKET COMPETITION BY MANUFACTURERS

2.1 Global Live Attenuated Vaccine Capacity, Production and Share by Manufacturers (2012-2017)
  2.1.1 Global Live Attenuated Vaccine Capacity and Share by Manufacturers (2012-2017)
  2.1.2 Global Live Attenuated Vaccine Production and Share by Manufacturers (2012-2017)
2.2 Global Live Attenuated Vaccine Revenue and Share by Manufacturers (2012-2017)
2.3 Global Live Attenuated Vaccine Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Live Attenuated Vaccine Manufacturing Base Distribution, Sales Area and Product Type
2.5 Live Attenuated Vaccine Market Competitive Situation and Trends
  2.5.1 Live Attenuated Vaccine Market Concentration Rate
  2.5.2 Live Attenuated Vaccine Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL LIVE ATTENUATED VACCINE CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

3.1 Global Live Attenuated Vaccine Capacity and Market Share by Region (2012-2017)
3.2 Global Live Attenuated Vaccine Production and Market Share by Region (2012-2017)
3.3 Global Live Attenuated Vaccine Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Live Attenuated Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Live Attenuated Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Live Attenuated Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Live Attenuated Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Live Attenuated Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Live Attenuated Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Live Attenuated Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 GLOBAL LIVE ATTENUATED VACCINE SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGION (2012-2017)

4.1 Global Live Attenuated Vaccine Consumption by Region (2012-2017)
4.2 North America Live Attenuated Vaccine Production, Consumption, Export, Import (2012-2017)
4.3 Europe Live Attenuated Vaccine Production, Consumption, Export, Import (2012-2017)
4.4 China Live Attenuated Vaccine Production, Consumption, Export, Import (2012-2017)
4.5 Japan Live Attenuated Vaccine Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Live Attenuated Vaccine Production, Consumption, Export, Import (2012-2017)
4.7 India Live Attenuated Vaccine Production, Consumption, Export, Import (2012-2017)

5 GLOBAL LIVE ATTENUATED VACCINE PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Live Attenuated Vaccine Production and Market Share by Type (2012-2017)
5.2 Global Live Attenuated Vaccine Revenue and Market Share by Type (2012-2017)
5.3 Global Live Attenuated Vaccine Price by Type (2012-2017)
5.4 Global Live Attenuated Vaccine Production Growth by Type (2012-2017)

6 GLOBAL LIVE ATTENUATED VACCINE MARKET ANALYSIS BY APPLICATION

6.1 Global Live Attenuated Vaccine Consumption and Market Share by Application (2012-2017)
6.2 Global Live Attenuated Vaccine Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL LIVE ATTENUATED VACCINE MANUFACTURERS PROFILES/ANALYSIS

7.1 Astellas Pharma (Japan)
  7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.1.2 Live Attenuated Vaccine Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 Astellas Pharma (Japan) Live Attenuated Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Main Business/Business Overview
7.2 CSL Limited (Australia)
  7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.2.2 Live Attenuated Vaccine Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 CSL Limited (Australia) Live Attenuated Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Main Business/Business Overview
7.3 Emergent BioSolutions (U.S.)
  7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.3.2 Live Attenuated Vaccine Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 Emergent BioSolutions (U.S.) Live Attenuated Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Main Business/Business Overview
7.4 GlaxoSmithKline (U.K.)
  7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.4.2 Live Attenuated Vaccine Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 GlaxoSmithKline (U.K.) Live Attenuated Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Main Business/Business Overview
7.5 Johnson & Johnson (U.S.)
  7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.5.2 Live Attenuated Vaccine Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 Johnson & Johnson (U.S.) Live Attenuated Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Main Business/Business Overview
7.6 MedImmune (U.S.)
  7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.6.2 Live Attenuated Vaccine Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 MedImmune (U.S.) Live Attenuated Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Main Business/Business Overview
7.7 Merck & Co (U.S.)
  7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.7.2 Live Attenuated Vaccine Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 Merck & Co (U.S.) Live Attenuated Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Main Business/Business Overview
7.8 Pfizer (U.S.)
  7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.8.2 Live Attenuated Vaccine Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 Pfizer (U.S.) Live Attenuated Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Main Business/Business Overview
7.9 Sanofi Pasteur (France)
  7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.9.2 Live Attenuated Vaccine Product Category, Application and Specification
    7.9.2.1 Product A
    7.9.2.2 Product B
  7.9.3 Sanofi Pasteur (France) Live Attenuated Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Main Business/Business Overview
7.10 Serum Institute of India Pvt (India)
  7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.10.2 Live Attenuated Vaccine Product Category, Application and Specification
    7.10.2.1 Product A
    7.10.2.2 Product B
  7.10.3 Serum Institute of India Pvt (India) Live Attenuated Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.10.4 Main Business/Business Overview

8 LIVE ATTENUATED VACCINE MANUFACTURING COST ANALYSIS

8.1 Live Attenuated Vaccine Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Live Attenuated Vaccine

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Live Attenuated Vaccine Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Live Attenuated Vaccine Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL LIVE ATTENUATED VACCINE MARKET FORECAST (2017-2022)

12.1 Global Live Attenuated Vaccine Capacity, Production, Revenue Forecast (2017-2022)
  12.1.1 Global Live Attenuated Vaccine Capacity, Production and Growth Rate Forecast (2017-2022)
  12.1.2 Global Live Attenuated Vaccine Revenue and Growth Rate Forecast (2017-2022)
  12.1.3 Global Live Attenuated Vaccine Price and Trend Forecast (2017-2022)
12.2 Global Live Attenuated Vaccine Production, Consumption, Import and Export Forecast by Region (2017-2022)
  12.2.1 North America Live Attenuated Vaccine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.2 Europe Live Attenuated Vaccine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.3 China Live Attenuated Vaccine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.4 Japan Live Attenuated Vaccine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.5 Southeast Asia Live Attenuated Vaccine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.6 India Live Attenuated Vaccine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Live Attenuated Vaccine Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Live Attenuated Vaccine Consumption Forecast by Application (2017-2022)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology/Research Approach
  14.1.1 Research Programs/Design
  14.1.2 Market Size Estimation
  14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
  14.2.1 Secondary Sources
  14.2.2 Primary Sources
14.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Live Attenuated Vaccine
Figure Global Live Attenuated Vaccine Production (K Pcs) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Live Attenuated Vaccine Production Market Share by Types (Product Category) in 2016
Figure Product Picture of Pediatrics
Table Major Manufacturers of Pediatrics
Figure Product Picture of Adults
Table Major Manufacturers of Adults
Figure Global Live Attenuated Vaccine Consumption (K Pcs) by Applications (2012-2022)
Figure Global Live Attenuated Vaccine Consumption Market Share by Applications in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Medical Center Examples
Table Key Downstream Customer in Medical Center
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Live Attenuated Vaccine Market Size (Million USD), Comparison (K Pcs) and CAGR (%) by Regions (2012-2022)
Figure North America Live Attenuated Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Live Attenuated Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Live Attenuated Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Live Attenuated Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Live Attenuated Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Live Attenuated Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Live Attenuated Vaccine Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Live Attenuated Vaccine Capacity, Production (K Pcs) Status and Outlook (2012-2022)
Figure Global Live Attenuated Vaccine Major Players Product Capacity (K Pcs) (2012-2017)
Table Global Live Attenuated Vaccine Capacity (K Pcs) of Key Manufacturers (2012-2017)
Table Global Live Attenuated Vaccine Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Live Attenuated Vaccine Capacity (K Pcs) of Key Manufacturers in 2016
Figure Global Live Attenuated Vaccine Capacity (K Pcs) of Key Manufacturers in 2017
Figure Global Live Attenuated Vaccine Major Players Product Production (K Pcs) (2012-2017)
Table Global Live Attenuated Vaccine Production (K Pcs) of Key Manufacturers (2012-2017)
Table Global Live Attenuated Vaccine Production Share by Manufacturers (2012-2017)
Figure 2016 Live Attenuated Vaccine Production Share by Manufacturers
Figure 2017 Live Attenuated Vaccine Production Share by Manufacturers
Figure Global Live Attenuated Vaccine Major Players Product Revenue (Million USD) (2012-2017)
Table Global Live Attenuated Vaccine Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Live Attenuated Vaccine Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Live Attenuated Vaccine Revenue Share by Manufacturers
Table 2017 Global Live Attenuated Vaccine Revenue Share by Manufacturers
Table Global Market Live Attenuated Vaccine Average Price (USD/Pcs) of Key Manufacturers (2012-2017)
Figure Global Market Live Attenuated Vaccine Average Price (USD/Pcs) of Key Manufacturers in 2016
Table Manufacturers Live Attenuated Vaccine Manufacturing Base Distribution and Sales Area
Table Manufacturers Live Attenuated Vaccine Product Category
Figure Live Attenuated Vaccine Market Share of Top 3 Manufacturers
Figure Live Attenuated Vaccine Market Share of Top 5 Manufacturers
Table Global Live Attenuated Vaccine Capacity (K Pcs) by Region (2012-2017)
Figure Global Live Attenuated Vaccine Capacity Market Share by Region (2012-2017)
Figure Global Live Attenuated Vaccine Capacity Market Share by Region (2012-2017)
Figure 2016 Global Live Attenuated Vaccine Capacity Market Share by Region
Table Global Live Attenuated Vaccine Production by Region (2012-2017)
Figure Global Live Attenuated Vaccine Production (K Pcs) by Region (2012-2017)
Figure Global Live Attenuated Vaccine Production Market Share by Region (2012-2017)
Figure 2016 Global Live Attenuated Vaccine Production Market Share by Region
Table Global Live Attenuated Vaccine Revenue (Million USD) by Region (2012-2017)
Table Global Live Attenuated Vaccine Revenue Market Share by Region (2012-2017)
Figure Global Live Attenuated Vaccine Revenue Market Share by Region (2012-2017)
Table 2016 Global Live Attenuated Vaccine Revenue Market Share by Region
Figure Global Live Attenuated Vaccine Capacity, Production (K Pcs) and Growth Rate (2012-2017)
Table Global Live Attenuated Vaccine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table North America Live Attenuated Vaccine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Europe Live Attenuated Vaccine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table China Live Attenuated Vaccine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Japan Live Attenuated Vaccine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Southeast Asia Live Attenuated Vaccine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table India Live Attenuated Vaccine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Global Live Attenuated Vaccine Consumption (K Pcs) Market by Region (2012-2017)
Table Global Live Attenuated Vaccine Consumption Market Share by Region (2012-2017)
Figure Global Live Attenuated Vaccine Consumption Market Share by Region (2012-2017)
Figure 2016 Global Live Attenuated Vaccine Consumption (K Pcs) Market Share by Region
Table North America Live Attenuated Vaccine Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Europe Live Attenuated Vaccine Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table China Live Attenuated Vaccine Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Japan Live Attenuated Vaccine Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Southeast Asia Live Attenuated Vaccine Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table India Live Attenuated Vaccine Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Global Live Attenuated Vaccine Production (K Pcs) by Type (2012-2017)
Table Global Live Attenuated Vaccine Production Share by Type (2012-2017)
Figure Production Market Share of Live Attenuated Vaccine by Type (2012-2017)
Figure 2016 Production Market Share of Live Attenuated Vaccine by Type
Table Global Live Attenuated Vaccine Revenue (Million USD) by Type (2012-2017)
Table Global Live Attenuated Vaccine Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Live Attenuated Vaccine by Type (2012-2017)
Figure 2016 Revenue Market Share of Live Attenuated Vaccine by Type
Table Global Live Attenuated Vaccine Price (USD/Pcs) by Type (2012-2017)
Figure Global Live Attenuated Vaccine Production Growth by Type (2012-2017)
Table Global Live Attenuated Vaccine Consumption (K Pcs) by Application (2012-2017)
Table Global Live Attenuated Vaccine Consumption Market Share by Application (2012-2017)
Figure Global Live Attenuated Vaccine Consumption Market Share by Applications (2012-2017)
Figure Global Live Attenuated Vaccine Consumption Market Share by Application in 2016
Table Global Live Attenuated Vaccine Consumption Growth Rate by Application (2012-2017)
Figure Global Live Attenuated Vaccine Consumption Growth Rate by Application (2012-2017)
Table Astellas Pharma (Japan) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Astellas Pharma (Japan) Live Attenuated Vaccine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Astellas Pharma (Japan) Live Attenuated Vaccine Production Growth Rate (2012-2017)
Figure Astellas Pharma (Japan) Live Attenuated Vaccine Production Market Share (2012-2017)
Figure Astellas Pharma (Japan) Live Attenuated Vaccine Revenue Market Share (2012-2017)
Table CSL Limited (Australia) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CSL Limited (Australia) Live Attenuated Vaccine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure CSL Limited (Australia) Live Attenuated Vaccine Production Growth Rate (2012-2017)
Figure CSL Limited (Australia) Live Attenuated Vaccine Production Market Share (2012-2017)
Figure CSL Limited (Australia) Live Attenuated Vaccine Revenue Market Share (2012-2017)
Table Emergent BioSolutions (U.S.) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Emergent BioSolutions (U.S.) Live Attenuated Vaccine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Emergent BioSolutions (U.S.) Live Attenuated Vaccine Production Growth Rate (2012-2017)
Figure Emergent BioSolutions (U.S.) Live Attenuated Vaccine Production Market Share (2012-2017)
Figure Emergent BioSolutions (U.S.) Live Attenuated Vaccine Revenue Market Share (2012-2017)
Table GlaxoSmithKline (U.K.) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline (U.K.) Live Attenuated Vaccine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline (U.K.) Live Attenuated Vaccine Production Growth Rate (2012-2017)
Figure GlaxoSmithKline (U.K.) Live Attenuated Vaccine Production Market Share (2012-2017)
Figure GlaxoSmithKline (U.K.) Live Attenuated Vaccine Revenue Market Share (2012-2017)
Table Johnson & Johnson (U.S.) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson (U.S.) Live Attenuated Vaccine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Johnson & Johnson (U.S.) Live Attenuated Vaccine Production Growth Rate (2012-2017)
Figure Johnson & Johnson (U.S.) Live Attenuated Vaccine Production Market Share (2012-2017)
Figure Johnson & Johnson (U.S.) Live Attenuated Vaccine Revenue Market Share (2012-2017)
Table MedImmune (U.S.) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table MedImmune (U.S.) Live Attenuated Vaccine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure MedImmune (U.S.) Live Attenuated Vaccine Production Growth Rate (2012-2017)
Figure MedImmune (U.S.) Live Attenuated Vaccine Production Market Share (2012-2017)
Figure MedImmune (U.S.) Live Attenuated Vaccine Revenue Market Share (2012-2017)
Table Merck & Co (U.S.) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck & Co (U.S.) Live Attenuated Vaccine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merck & Co (U.S.) Live Attenuated Vaccine Production Growth Rate (2012-2017)
Figure Merck & Co (U.S.) Live Attenuated Vaccine Production Market Share (2012-2017)
Figure Merck & Co (U.S.) Live Attenuated Vaccine Revenue Market Share (2012-2017)
Table Pfizer (U.S.) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer (U.S.) Live Attenuated Vaccine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer (U.S.) Live Attenuated Vaccine Production Growth Rate (2012-2017)
Figure Pfizer (U.S.) Live Attenuated Vaccine Production Market Share (2012-2017)
Figure Pfizer (U.S.) Live Attenuated Vaccine Revenue Market Share (2012-2017)
Table Sanofi Pasteur (France) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Pasteur (France) Live Attenuated Vaccine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sanofi Pasteur (France) Live Attenuated Vaccine Production Growth Rate (2012-2017)
Figure Sanofi Pasteur (France) Live Attenuated Vaccine Production Market Share (2012-2017)
Figure Sanofi Pasteur (France) Live Attenuated Vaccine Revenue Market Share (2012-2017)
Table Serum Institute of India Pvt (India) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Serum Institute of India Pvt (India) Live Attenuated Vaccine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Serum Institute of India Pvt (India) Live Attenuated Vaccine Production Growth Rate (2012-2017)
Figure Serum Institute of India Pvt (India) Live Attenuated Vaccine Production Market Share (2012-2017)
Figure Serum Institute of India Pvt (India) Live Attenuated Vaccine Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Live Attenuated Vaccine
Figure Manufacturing Process Analysis of Live Attenuated Vaccine
Figure Live Attenuated Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Live Attenuated Vaccine Major Manufacturers in 2016
Table Major Buyers of Live Attenuated Vaccine
Table Distributors/Traders List
Figure Global Live Attenuated Vaccine Capacity, Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Global Live Attenuated Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Live Attenuated Vaccine Price (Million USD) and Trend Forecast (2017-2022)
Table Global Live Attenuated Vaccine Production (K Pcs) Forecast by Region (2017-2022)
Figure Global Live Attenuated Vaccine Production Market Share Forecast by Region (2017-2022)
Table Global Live Attenuated Vaccine Consumption (K Pcs) Forecast by Region (2017-2022)
Figure Global Live Attenuated Vaccine Consumption Market Share Forecast by Region (2017-2022)
Figure North America Live Attenuated Vaccine Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure North America Live Attenuated Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Live Attenuated Vaccine Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure Europe Live Attenuated Vaccine Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Europe Live Attenuated Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Live Attenuated Vaccine Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure China Live Attenuated Vaccine Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure China Live Attenuated Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Live Attenuated Vaccine Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure Japan Live Attenuated Vaccine Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Japan Live Attenuated Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Live Attenuated Vaccine Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure Southeast Asia Live Attenuated Vaccine Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Live Attenuated Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Live Attenuated Vaccine Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure India Live Attenuated Vaccine Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure India Live Attenuated Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Live Attenuated Vaccine Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Table Global Live Attenuated Vaccine Production (K Pcs) Forecast by Type (2017-2022)
Figure Global Live Attenuated Vaccine Production (K Pcs) Forecast by Type (2017-2022)
Table Global Live Attenuated Vaccine Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Live Attenuated Vaccine Revenue Market Share Forecast by Type (2017-2022)
Table Global Live Attenuated Vaccine Price Forecast by Type (2017-2022)
Table Global Live Attenuated Vaccine Consumption (K Pcs) Forecast by Application (2017-2022)
Figure Global Live Attenuated Vaccine Consumption (K Pcs) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source